A deep-learning based artificial intelligence (AI) approach for differentiation of clear cell renal cell carcinoma from oncocytoma on multi-phasic MRI.

Journal: Clinical imaging
PMID:

Abstract

PURPOSE: To investigate the diagnostic performance of a deep convolutional neural network for differentiation of clear cell renal cell carcinoma (ccRCC) from renal oncocytoma.

Authors

  • Moozhan Nikpanah
    Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Building 10, 9000 Rockville Pike, Bethesda, MD 20892, USA.
  • Ziyue Xu
    Center for Infectious Disease Imaging (CIDI), Radiology and Imaging Science Department, National Institutes of Health (NIH), Bethesda, MD 20892, United States.
  • Dakai Jin
  • Faraz Farhadi
    Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD.
  • Babak Saboury
    IBM Research, Almaden, San Jose, California.
  • Mark W Ball
  • Rabindra Gautam
    Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Maria J Merino
    Center for Interventional Oncology, National Cancer Institute & Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Bradford J Wood
    Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Baris Turkbey
    Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Elizabeth C Jones
    Clinical Center, National Institutes of Health, Bethesda, MD, United States.
  • W Marston Linehan
    Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Ashkan A Malayeri
    Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD.